Search the research

6 results for “IPO” in Oorjita Anveshan

1. Oorjita AnveshanThu, 12 Feb, 2026

   Sudeep Pharma: 39.7% EBITDA Margins and Capacity Doubling After Its IPO

   with 35+ years of expertise in mineral chemistries, the company recently listed on NSE/BSE on November

   41 min read
   
2. Oorjita AnveshanMon, 6 Oct, 2025

   Tata Capital IPO: The Complete Deep Dive

   P/B (pre‑offer ₹79.5 Price / BVPS 4.1× Official BV NAV) (pre‑offer

   3 min read
   
3. Oorjita AnveshanFri, 21 Nov, 2025

   Mankind Pharma: India's No. 4 Drugmaker, Down 13.5%, Lags Peers on Profitability

   Mankind Pharma is India’s 4th largest pharmaceutical company by domestic market

   87 min read
   
4. Oorjita AnveshanMon, 16 Feb, 2026

   Advait Energy Transitions: A Green-Hydrogen Pivot, Priced 25–40% Too High

   India's power transmission network requires massive expansion to support the target

   91 min read
   
5. Oorjita AnveshanSun, 2 Nov, 2025

   Sanathan Textiles: Tripling Polyester Capacity in Punjab, 40% From Premium Yarns

   SANATHAN) is a vertically integrated manufacturer of polyester yarns (77% revenue), cotton

   5 min read
   
6. Oorjita AnveshanSun, 2 Nov, 2025

   Alivus Life Sciences: Margins Expand Even After Losing PLI Benefits

   Strong YoY growth in revenue and profitability, margin expansion, and operational efficiency

   8 min read